Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis

被引:1
|
作者
Nejati, Parham [1 ]
Attar, Marzieh [1 ]
Rahimian, Maryam [1 ]
Fathi, Davood [2 ]
Shahbazi, Majid [1 ]
机构
[1] Golestan Univ Med Sci, Med Cellular & Mol Res Ctr, Azar Univ Hosp 5, Gorgan, Iran
[2] Golestan Univ Med Sci, Dept Neurol, Azar Univ Hosp 5, Gorgan, Iran
关键词
MBP; MS; PCR; Polymorphism; VNTR; SUSCEPTIBILITY; ASSOCIATION; IDENTIFICATION; EXPRESSION; HAPLOTYPES; ALLELES; MS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Multiple sclerosis (MS), as a multifactorial autoimmune disease with complex genetic basis, causes demyelination in the central nervous system via cytokine responses to myelin antigens. Myelin basic protein (MBP) is the main protein component of the myelin sheath. HLA-DRB (human leukocyte antigen-DR beta) alleles, particularly HLA-DRB1*1501, may be of significance in the pathogenesis of MS. Objective: To examine the association of HLA-DRB1*1501 alleles and MBP VNTR (variable number tandem repeat) polymorphism with the MS susceptibility in Iranian population. Methods: Genomic DNA was extracted from peripheral blood. The alleles were determined by the Polymerase Chain Reaction (PCR) method in 259 MS patients and 312 healthy control individuals and analyses were carried out using Fisher's exact test. Results: The frequencies of MBP VNTR genotypes (AA, AB and BB) were 47%, 42% and 11% among patients, and 45%, 43% and 12% in control subjects, respectively. HLA-DRB1*1501 allele was more frequent among patients than healthy individuals (OR=1.65, P=0.0045). The frequency of allele A and genotype A/A was significantly higher among HLA-DRB1*1501 positive patients (61% and 32%) than controls (46% and 19%) (OR=1.88, P=0.0013; A/A vs. B/B: OR=5.09, P=0.0004). The two-locus analysis of the interaction between the MBP VNTR polymorphism and the HLA-DRB1 allele showed that the HLADRB1*1501/A haplotype was more frequent among MS patients than the healthy controls. Conclusion: The interaction between the HLADRB1*1501 allele and MBP gene may be considered as a predisposing factor in the development and pathogenesis of MS in the case of gene-gene interaction.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 50 条
  • [21] HLA-DRB1 susceptibility in multiple sclerosis Algerian patients
    Hecham, N.
    Tazir, M.
    Boudjella, M. L.
    Benhalima, M.
    Pacha, L. Ali
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 360 - 361
  • [22] HLA-DRB1 and multiple sclerosis in Malta
    Dean, G.
    Yeo, T. W.
    Goris, A.
    Taylor, C. J.
    Goodman, R. S.
    Elian, M.
    Galea-Debono, A.
    Aquilina, A.
    Felice, A.
    Vella, M.
    Sawcer, S.
    Compston, D. A. S.
    NEUROLOGY, 2008, 70 (02) : 101 - 105
  • [23] HLA-DRB1 and multiple sclerosis in Argentina
    Patrucco, L.
    Larriba, J.
    Redal, M. A.
    Rojas, J. I.
    Argibay, P. F.
    Cristiano, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (03) : 427 - 429
  • [24] HLA-DRB1 AND MULTIPLE SCLEROSIS IN MALTA
    Ramagopalan, S. V.
    Dyment, D. A.
    Sadovnick, A. D.
    Ebers, G. C.
    NEUROLOGY, 2008, 71 (17) : 1379 - 1379
  • [25] Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population
    Balnyte, Renata
    Rastenyte, Daiva
    Mickeviciene, Dalia
    Vaitkus, Antanas
    Skrodeniene, Erika
    Vitkauskiene, Astra
    MEDICINA-LITHUANIA, 2012, 48 (01): : 9 - 14
  • [26] HLA-DRB1 gene polymorphisms in Iranian children with Henoch-Schonlein purpura
    Rashidi, Saadyeh
    Shiari, Reza
    Farivar, Shirin
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
  • [27] High frequency of the IL-2-330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis
    Shahbazi, Majid
    Roshandel, Danial
    Ebadi, Hamid
    Fathi, Davood
    Zamani, Mandi
    Boghaee, Mojdeh
    Mohammadhoseeeni, Mana
    Rshaidbaghan, Azam
    Bakhshandeh, Azam
    Shahbazi, Saleh
    CLINICAL IMMUNOLOGY, 2010, 137 (01) : 134 - 138
  • [28] A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients
    Ban, M
    Sawcer, SJ
    Heard, RNS
    Bennetts, BH
    Adams, S
    Booth, D
    Perich, V
    Setakis, E
    Compston, A
    Stewart, GJ
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 143 (1-2) : 60 - 64
  • [29] HIGH FREQUENCY OF THE IL-2-330 T/HLA-DRB1☆1501 HAPLOTYPE IN PATIENTS WITH MULTIPLE SCLEROSIS
    Shahbazi, M.
    Roshandel, D.
    Ebadi, H.
    Fathi, D.
    Zamani, M.
    Boghaee, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 261 - 261
  • [30] Integrating risk factors - HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis
    De Jager, P. L.
    Simon, K. C.
    Munger, K. L.
    Rioux, J. D.
    Hafler, D. A.
    Ascherio, A.
    NEUROLOGY, 2008, 70 (13) : 1113 - 1118